Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Ulcerative Colitis - APRISOTM Granted FDA Marketing Approval for Maintenance of Remission of Ulcerative Colitis
Urology - New urology study findings have been reported by scientists at University of Oklahoma
Viaspace Inc. - VIASPACE Meets With Customers at Largest U.S. Fuel Cell Show
ZymoGenetics, Inc. - ZymoGenetics Presents Positive Interim Phase 1b Results in Hepatitis C
Breast Cancer - New breast cancer study results from University of Tsukuba described
Cancer Vaccines - Canopus Biopharma Announces Positive Results In Human Study of Novel Peptide Cancer Vaccine
Canopus BioPharma, Inc. - Working with U.S. Department of Defense, Canopus BioPharma Announces Phase II Human Clinical Trial for Innovative Hepatitis C Drug, CB5300
HIV/AIDS - Tibotec Presents Interim Findings for Tmc435, an Investigational Genotype 1 Hepatitis C Treatment, At the Aasld Liver Meeting 2008
I-Flow Corporation - I-Flow Reports 14% Increase in 2008 Third Quarter Total Revenue to $32.2 Million Compared to $28.2 Million for the Third Quarter of 2007
IOGEAR, Inc. - IOGEAR's New KVM Brings Images and Sound to Life for Audio and Gaming Enthusiasts
Nucryst Pharmaceuticals Corp. - New Acticoat Silver Coated Anti-microbial Barrier Dressing Receives Regulatory Approval from Health Canada
Obesity and Diabetes - Non-Brain Penetrant CB1 Antagonists from Jenrin Discovery Show Beneficial Effects in Treating Diabetes and Obesity
Onyx Pharmaceuticals, Inc. - Onyx Pharmaceuticals Licenses Rights to Novel Targeted Oncology Agent From BTG International
Scolr Pharma, Inc. - SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results